<?xml version="1.0" encoding="UTF-8"?>
<p>To date, we know that COVID-19 is a respiratory ailment, with the majority of affected people developing only mild to moderate symptoms and improving without the need of intensive management [
 <xref rid="B17-molecules-25-05017" ref-type="bibr">17</xref>]. However, individuals with previous comorbidities (e.g., cardiovascular disease, diabetes, chronic respiratory disease, and cancer) and those above 60 years of age are at a greater risk of developing severe clinical form [
 <xref rid="B18-molecules-25-05017" ref-type="bibr">18</xref>], known as acute respiratory distress syndrome (ARDS). The most common symptoms for COVID-19 are moderate to high-grade fever, tiredness, and dry cough. Additional symptoms may also include shortness of breath, body aches, sore throat, and very few individuals also experience diarrhea, nausea or a runny nose [
 <xref rid="B19-molecules-25-05017" ref-type="bibr">19</xref>]. SARS-CoV-2 attacks the respiratory tract causing similar clinical symptoms to SARS-CoV and the Middle East respiratory syndrome coronavirus (MERS-CoV) [
 <xref rid="B20-molecules-25-05017" ref-type="bibr">20</xref>].
</p>
